Parviz Ranjbarvan

ORCID: 0000-0003-1460-1651 · 1 paper in corpus

article 2021

Comparison of raloxifene effect on the growth and angiogenesis of human endometrium of healthy and endometriosis subjects: An in vitro three-dimensional tissue culture model

·doi:10.1177/22840265211018310

Introduction: Raloxifene (Ral) is the oldest SERM (selective oestrogen receptor modulators) for treatment of breast cancer and osteoporosis. Its oestrogen-modulating effects have been shown in breast and uterus. Since there is little availa…